A

argenx

Develops antibody-based therapies for autoimmune diseases

US Patent Attorney – Senior Patent Counsel - Program Strategy & Litigation

Intellectual Property (IP)Updated on Nov 12
Full-time

About the Job

Requirements

  • A Juris Doctor degree, active membership in good standing in at least one United States state bar, and registration to practice before the United States Patent and Trademark Office are required.
  • At least eight years of life sciences patent experience, including substantial hands-on United States BPCIA or ANDA patent litigation or contested-matter experience and demonstrated ability to lead complex disputes or major workstreams, is required. Large-molecule experience is required.
  • Ability to connect litigation risk and enforcement objectives with portfolio development, prosecution, and business strategy, and to lead selected programs alongside contested matters.
  • Genuine, demonstrable curiosity and willingness to learn emerging artificial intelligence capabilities, question established processes, experiment responsibly, and help colleagues adopt improved ways of working.
  • Strong legal and business judgment; ability to explain complex issues clearly, make practical recommendations, and collaborate across scientific, commercial, and legal teams.

Responsibilities

  • Develop creative, business-aligned protection and enforcement strategies, leveraging litigation experience to drive portfolio value; build and manage global portfolios and oversee patent preparation, filing, and prosecution in the United States, Europe, and other jurisdictions worldwide.
  • Strengthen litigation readiness and lead or support patent disputes with internal colleagues and external counsel, connecting prosecution, records, and enforcement strategy.
  • Lead global intellectual property dispute strategy and execution with the Head of Litigation and Enforcement, other Legal, Compliance and Intellectual Property colleagues, and external counsel; cover patent litigation, biosimilar disputes, patent-office challenges and oppositions, and related trade secret or contractual disputes; align positions across jurisdictions and related matters.
  • Act as strategic intellectual property partner to global project teams responsible for key drug candidates, translating complex science and patent issues into recommendations that support product development, commercialization, and long-term portfolio value.
  • Work with scientists to identify and protect inventions, assess inventorship, manage public disclosures, and strengthen trade secret protection.
  • Conduct infringement, validity, freedom-to-operate, and competitive landscape analyses, identifying actionable risks and opportunities.
  • Lead patent-related diligence and support licensing, collaborations, partnerships, mergers, and acquisitions; review, draft, and negotiate intellectual property provisions and agreements, including confidentiality, technology transfer, and licensing arrangements.
  • Manage external counsel and business partners, align priorities and resources, and deliver portfolio reviews, long-range planning, and special projects.
  • Evaluate infringement, validity, enforceability, evidence, and business exposure; develop enforcement, defense, and settlement options; communicate recommendations and decision points; and seek appropriate internal approvals.
  • Select and direct external counsel in global intellectual property litigations and contested matters with the Global Head of IP; oversee case plans, budgets, discovery, experts, witnesses, and key submissions; liaise with the Head of Litigation and Enforcement and relevant colleagues on material risks, escalation, resourcing, and coordinated matter management.
  • Lead pre-dispute planning and biosimilar readiness; work with colleagues and business teams on evidence preservation, legal holds, witness preparation, and strengthening invention, prosecution, and development records.
  • Lead patent strategy for assigned programs, including global portfolio development, prosecution, invention and disclosure management, and freedom-to-operate assessment; maintain scientific and business partnerships.
  • Partner with program attorneys to strengthen defensibility and enforcement options across the portfolio, and feed dispute lessons into prosecution and trade secret practices without assuming ownership of every program.
  • Support selected diligence, licensing, and collaboration matters, focusing on dispute exposure, enforcement rights, and litigation-control provisions while balancing assignments against contested-matter priorities.
  • Pilot approved agent-assisted workflows for dispute monitoring, evidence chronologies, document triage, reference verification, and matter reporting; begin with bounded use cases and improve them through feedback.
  • Define tasks, authoritative inputs, review checkpoints, and escalation rules for agent-assisted work; verify outputs and references, protect confidential and privileged information, respect data-use restrictions, and retain attorney accountability for legal advice and consequential decisions.
  • Partner with intellectual property operations, technology, and other colleagues to turn useful pilots into repeatable practices; share learning, coach colleagues, and assess improvements in quality, responsiveness, and capacity.

Desired Qualifications

  • An advanced life sciences degree, preferably at least a thesis-based master's degree in biology or a related field.
  • Biosimilar litigation experience is strongly preferred. Patent-office challenges, cross-border disputes, trial or appeal experience, and licensing or settlement negotiations are valuable. Both law firm and in-house experience are welcome; law-firm-only candidates will also be considered.
  • Experience improving legal workflows or using artificial intelligence, automation, or knowledge tools is welcome. Prior agent-building experience and coding skills are not required; learning agility, sound judgment, and willingness to experiment are essential.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs